Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUK six panobinostat with VTD in relapsed multiple myeloma
ISRCTN59395590Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Dec 2012
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of panobinostat in multiple myeloma (MM), sponsored by University of Leeds. Primary endpoint: Dose-limiting toxicities. Started Dec 2012; status: completed.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ISRCTN59395590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN59395590.